New prescription drugs that spur weight loss and treat diabetes have been using the public—and the pharmaceutical marketplace—by storm. The most up-to-date entrant, Zepbound, just lately joined Ozempic, Wegovy, Victoza and Some others within a expanding class of medicines named GLP-1 receptor agonists.improvements in eyesight. Explain to your h